GB1370904A - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB1370904A GB1370904A GB5865871A GB5865871A GB1370904A GB 1370904 A GB1370904 A GB 1370904A GB 5865871 A GB5865871 A GB 5865871A GB 5865871 A GB5865871 A GB 5865871A GB 1370904 A GB1370904 A GB 1370904A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10994271A | 1971-01-26 | 1971-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1370904A true GB1370904A (en) | 1974-10-16 |
Family
ID=22330411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5865871A Expired GB1370904A (en) | 1971-01-26 | 1971-12-17 | Pharmaceutical composition |
Country Status (18)
| Country | Link |
|---|---|
| AT (2) | AT310938B (enExample) |
| AU (1) | AU465875B2 (enExample) |
| BE (2) | BE776769A (enExample) |
| BR (2) | BR7108429D0 (enExample) |
| CA (2) | CA986012A (enExample) |
| DD (2) | DD96144A5 (enExample) |
| DE (2) | DE2163054C3 (enExample) |
| DK (2) | DK130389B (enExample) |
| ES (2) | ES398108A1 (enExample) |
| FR (2) | FR2123277B1 (enExample) |
| GB (1) | GB1370904A (enExample) |
| HU (2) | HU162185B (enExample) |
| IE (2) | IE35937B1 (enExample) |
| LU (1) | LU64664A1 (enExample) |
| NL (2) | NL7117401A (enExample) |
| NO (2) | NO135891C (enExample) |
| SE (2) | SE391286B (enExample) |
| ZA (2) | ZA718326B (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8952152B2 (en) | 2009-03-24 | 2015-02-10 | Proteus S.A. | Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof |
| US8975281B2 (en) | 2013-03-15 | 2015-03-10 | The Children's Medical Center Corporation | Neosaxitoxin combination formulations for prolonged local anesthesia |
| US9018222B2 (en) | 2006-03-27 | 2015-04-28 | Wex Medical Limited | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4917894A (en) * | 1988-06-29 | 1990-04-17 | Beecham Inc. | Rapid-onset long-duration oral anesthetic composition |
| US6030974A (en) * | 1997-04-02 | 2000-02-29 | The Regents Of The University Of California | Method of anesthesia |
| WO1998051290A2 (en) * | 1997-05-16 | 1998-11-19 | Children's Medical Center Corporation | Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent |
| RU2277097C1 (ru) * | 2004-12-27 | 2006-05-27 | Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) | Высокомеченный тритием дигидрохлорид [3h]сакситоксина |
-
1971
- 1971-12-07 SE SE7115654A patent/SE391286B/xx unknown
- 1971-12-07 SE SE7115655A patent/SE391127B/xx unknown
- 1971-12-10 NO NO4557/71A patent/NO135891C/no unknown
- 1971-12-10 NO NO4558/71A patent/NO135892C/no unknown
- 1971-12-13 ZA ZA718326A patent/ZA718326B/xx unknown
- 1971-12-13 ZA ZA718327A patent/ZA718327B/xx unknown
- 1971-12-14 DK DK609571AA patent/DK130389B/da unknown
- 1971-12-16 HU HU71AA689A patent/HU162185B/hu unknown
- 1971-12-16 BE BE776769A patent/BE776769A/xx unknown
- 1971-12-16 BE BE776768A patent/BE776768A/xx unknown
- 1971-12-16 HU HUAA688A patent/HU162347B/hu unknown
- 1971-12-17 AT AT1084871A patent/AT310938B/de not_active IP Right Cessation
- 1971-12-17 DD DD159910A patent/DD96144A5/xx unknown
- 1971-12-17 DD DD159688A patent/DD96400A5/xx unknown
- 1971-12-17 FR FR7145542A patent/FR2123277B1/fr not_active Expired
- 1971-12-17 NL NL7117401A patent/NL7117401A/xx unknown
- 1971-12-17 NL NL7117404A patent/NL7117404A/xx not_active Application Discontinuation
- 1971-12-17 DK DK619971A patent/DK131606C/da active
- 1971-12-17 FR FR7145543A patent/FR2123278B1/fr not_active Expired
- 1971-12-17 CA CA130,378A patent/CA986012A/en not_active Expired
- 1971-12-17 AT AT1084971A patent/AT310939B/de not_active IP Right Cessation
- 1971-12-17 CA CA130,377A patent/CA983850A/en not_active Expired
- 1971-12-17 GB GB5865871A patent/GB1370904A/en not_active Expired
- 1971-12-18 DE DE2163054A patent/DE2163054C3/de not_active Expired
- 1971-12-18 ES ES398108A patent/ES398108A1/es not_active Expired
- 1971-12-18 ES ES398109A patent/ES398109A1/es not_active Expired
- 1971-12-18 DE DE19712163055 patent/DE2163055A1/de active Pending
- 1971-12-20 IE IE1611/71A patent/IE35937B1/xx unknown
- 1971-12-20 BR BR8429/71A patent/BR7108429D0/pt unknown
- 1971-12-20 IE IE1610/71A patent/IE35910B1/xx unknown
- 1971-12-20 BR BR8428/71A patent/BR7108428D0/pt unknown
- 1971-12-20 AU AU37100/71A patent/AU465875B2/en not_active Expired
-
1972
- 1972-01-26 LU LU64664D patent/LU64664A1/xx unknown
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9018222B2 (en) | 2006-03-27 | 2015-04-28 | Wex Medical Limited | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| US10149852B2 (en) | 2006-03-27 | 2018-12-11 | Wex Pharmaceuticals Inc. | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| US10624896B2 (en) | 2006-03-27 | 2020-04-21 | Wex Medical Limited | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| US11419873B2 (en) | 2006-03-27 | 2022-08-23 | Wex Medical Limited | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| US8952152B2 (en) | 2009-03-24 | 2015-02-10 | Proteus S.A. | Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof |
| US8957207B2 (en) | 2009-03-24 | 2015-02-17 | Proteus S.A. | Methods for producing phycotoxins |
| US9249150B2 (en) | 2009-03-24 | 2016-02-02 | Proteus S.A. | Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof |
| US8975281B2 (en) | 2013-03-15 | 2015-03-10 | The Children's Medical Center Corporation | Neosaxitoxin combination formulations for prolonged local anesthesia |
| US8975268B2 (en) | 2013-03-15 | 2015-03-10 | The Children's Medical Center Corporation | Neosaxitoxin combination formulations for prolonged local anesthesia |
| US10314833B2 (en) | 2013-03-15 | 2019-06-11 | The Children's Medical Center Corporation | Neosaxitoxin combination formulations for prolonged local anesthesia |
| US10881647B2 (en) | 2013-03-15 | 2021-01-05 | The Children's Medical Center Corporation | Neosaxitoxin combination formulations for prolonged local anesthesia |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE36891L (en) | Coronary-dilating composition | |
| AU5119173A (en) | Composition | |
| ZA723207B (en) | Slow release pharmaceutical compositions | |
| AU482733B2 (en) | Pharmaceutical compositions | |
| ZA727741B (en) | Thermofomable compositions | |
| IE35991L (en) | Camphor-containing pharmaceutical composition | |
| CY955A (en) | Pharmaceutical compositions | |
| CA974170A (en) | Pharmaceutical compositions | |
| GB1393014A (en) | Polyurethane-tar compositions | |
| IE35910B1 (en) | Pharmaceutical composition | |
| ZA713877B (en) | Pharmaceutical composition | |
| ZA721363B (en) | Pharmaceutical composition | |
| GB1367202A (en) | Reflex-reflecting compositions | |
| ZA721169B (en) | Pharmaceutical preparation | |
| CY755A (en) | Therapeutic composition | |
| ZA723908B (en) | Desensitizer composition | |
| IL39516A (en) | Substituted 4-propoxy-9-fluorenone compounds and pharmaceutical compositions containing them | |
| CA885421A (en) | Pharmaceutical composition | |
| CA884857A (en) | Pharmaceutical composition | |
| CA879074A (en) | Pharmaceutical compositions | |
| CA888155A (en) | Pharmaceutical compositions | |
| CA876689A (en) | Pharmaceutical compositions | |
| CA888688A (en) | Pharmaceutical compositions | |
| CA881476A (en) | Pharmaceutical compositions | |
| CA882088A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |